Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

1067P Steroid and antibiotic treatment are associated with diverse immunotherapy efficacy: A pooled analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC trials of the German AIO study group

Autor: Wiest, I., Keller, R., Marin-Galiano, M., Zengerling, F., Tintelnot, J., Grimm, M-O.J., Leucht, K., Bozorgmehr, F., Christopoulos, P., Rieken, S., Meran, J., Stein, A., Binder, M., Härtel, N., Klinghammer, K., Gruenwald, V., Pogorzelski, M., Ebert, M.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S707-S707

The drug-induced phenotypic landscape of colorectal cancer organoids.

Autor: Betge J; German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, and Heidelberg University, Medical Faculty Mannheim, Department of Cell and Molecular Biology, Heidelberg, Germany.; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; German Cancer Research Center (DKFZ), Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, Heidelberg, Germany.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Mannheim, Germany., Rindtorff N; German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, and Heidelberg University, Medical Faculty Mannheim, Department of Cell and Molecular Biology, Heidelberg, Germany., Sauer J; German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, and Heidelberg University, Medical Faculty Mannheim, Department of Cell and Molecular Biology, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Computational Genome Biology Group, Heidelberg, Germany., Rauscher B; German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, and Heidelberg University, Medical Faculty Mannheim, Department of Cell and Molecular Biology, Heidelberg, Germany., Dingert C; German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, and Heidelberg University, Medical Faculty Mannheim, Department of Cell and Molecular Biology, Heidelberg, Germany., Gaitantzi H; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Mannheim, Germany., Herweck F; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Mannheim, Germany., Srour-Mhanna K; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; German Cancer Research Center (DKFZ), Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, Heidelberg, Germany.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany., Miersch T; German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, and Heidelberg University, Medical Faculty Mannheim, Department of Cell and Molecular Biology, Heidelberg, Germany., Valentini E; German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, and Heidelberg University, Medical Faculty Mannheim, Department of Cell and Molecular Biology, Heidelberg, Germany., Boonekamp KE; German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, and Heidelberg University, Medical Faculty Mannheim, Department of Cell and Molecular Biology, Heidelberg, Germany., Hauber V; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Mannheim, Germany., Gutting T; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Mannheim, Germany.; Department of Internal Medicine IV, Heidelberg University, Heidelberg, Germany., Frank L; German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, and Heidelberg University, Medical Faculty Mannheim, Department of Cell and Molecular Biology, Heidelberg, Germany., Belle S; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Mannheim, Germany., Gaiser T; Mannheim Cancer Center, Mannheim, Germany.; Heidelberg University, Institute of Pathology, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany., Buchholz I; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Mannheim, Germany., Jesenofsky R; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Mannheim, Germany., Härtel N; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Mannheim, Germany., Zhan T; German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, and Heidelberg University, Medical Faculty Mannheim, Department of Cell and Molecular Biology, Heidelberg, Germany.; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Mannheim, Germany., Fischer B; German Cancer Research Center (DKFZ), Computational Genome Biology Group, Heidelberg, Germany., Breitkopf-Heinlein K; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Mannheim, Germany., Burgermeister E; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Mannheim, Germany., Ebert MP; Heidelberg University, Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Mannheim, Germany. matthias.ebert@medma.uni-heidelberg.de.; DKFZ-Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany. matthias.ebert@medma.uni-heidelberg.de.; Mannheim Cancer Center, Mannheim, Germany. matthias.ebert@medma.uni-heidelberg.de., Boutros M; German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics, and Heidelberg University, Medical Faculty Mannheim, Department of Cell and Molecular Biology, Heidelberg, Germany. m.boutros@dkfz.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. m.boutros@dkfz.de.

Publikováno v: Nature communications [Nat Commun] 2022 Jun 06; Vol. 13 (1), pp. 3135. Date of Electronic Publication: 2022 Jun 06.

Sequential Geriatric Assessment in Older Patients with Colorectal Cancer during Chemotherapy: Subgroup Analysis of a Prospective, Multicenter Study EpiReal 75.

Autor: Li M; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany, moying.li@umm.de.; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany, moying.li@umm.de., Schulte N; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Elting F; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Winkler EC; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany., Hetjens S; Department of Medical Statistics and Biomathematics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Berger AK; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany., Zschäbitz S; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany., Hofmann J; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Hofmann J; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Hilbertz L; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Kuhn M; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Khakzar C; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Jesenofsky R; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Betge J; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, German Cancer Research Center (DKFZ), Heidelberg, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany., Zhan T; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Belle S; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Ebert MP; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany., Härtel N; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Publikováno v: Oncology research and treatment [Oncol Res Treat] 2022; Vol. 45 (11), pp. 670-680. Date of Electronic Publication: 2022 Jun 08.

Influence of the zeolite pore structure on the kinetics of the disproportionation of ethylbenzene

Autor: Arsenova-Härtel, N., Bludau, H., Haag, W.O., Karge, H.G. ^*

Publikováno v: In Microporous and Mesoporous Materials 2000 35:113-119